Company: APM
Filing Date: 2025-12-05
Form Type: 424B5
Source: 0001213900-25-118752
Chunk: 143

Company: Aptorum Group Ltd
Filing Date: 2025-12-05
Form: 424B5
Chunk 143
---
b) domestic company that plans to, either directly or indirectly through its overseas
listed entity, publicly disclose or provide to relevant individuals and entities including securities companies, securities service providers
and overseas regulators, any other documents and materials that, if leaked, will be detrimental to national security or public interest,
shall strictly fulfill relevant procedures stipulated by applicable national regulations. As of the date hereof, we have not received
any formal inquiry, notice, warning, sanction, or objection from the CSRC with respect to the listing of Aptorum Class A ordinary
shares. However, there remains significant uncertainty as to the enactment, interpretation and implementation of regulatory requirements
related to overseas securities offerings and other capital markets activities. If it is determined that we are subject to the Trial Measures
for the listing of the Ordinary Shares on the Nasdaq, we may fail to obtain required approval, complete required filing or meet such requirements
in a timely manner or at all, or completion could be rescinded. Any failure or perceived failure of us to fully comply with such new regulatory
requirements could significantly limit or completely hinder our ability to offer or continue to offer securities to investors, cause significant
disruption to our business operations, and severely damage our reputation, which could materially and adversely affect our financial condition
and results of operations and could cause the value of our securities to significantly decline or be worthless.

<div align='center'>75</div>

If we are determined to be
subject to the Draft Rules Regarding Overseas Listings, we cannot assure you that we will be able to receive clearance of such filing
requirements in a timely manner, or at all, even though we believe that none of the situations that would clearly prohibit overseas listing
and offering applies to us. Based on laws and regulations currently in effect in the PRC as of the date hereof, we believe our Hong Kong
subsidiaries are not required to obtain regulatory approval from the CSRC in order to list Aptorum Class A ordinary shares in the
U.S.

Since these proposed rules,
statements and regulatory actions are new, it is highly uncertain how soon the legislative or administrative regulation making bodies
will respond and what existing or new laws or regulations or detailed implementations and interpretations will be modified or promulgated,
if any. Any failure of us to full comply with new regulatory requirements may significantly limit or completely hinder our ability to
offer or continue to offer the Aptorum Class A ordinary shares, cause significant disruption to our business operations, severely
damage our reputation, materially and adversely affect our